More on AUPH

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+43.8% Growth)
- Ratings (6.7 Score)
- Holders

Upcoming Events

- Earnings (7/30/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Aurinia Pharmaceuticals (NQ:AUPH)
Delayed: 16.46 +0.32 (1.98%)
Prev. Close $16.14  
Open$16.44 
52 Wk High$5.69 
52 Wk Low$1.42 
Day High$16.50 
Day Low$16.21 
P/E N/A  
EPS$0.00 
Volume1,172,339 


Jun 8, 2026 04:14 PM Form 4 Aurinia Pharmaceuticals For: Jun 04 Filed by: Johnson Craig A
Jun 8, 2026 04:12 PM Form 4 Aurinia Pharmaceuticals For: Jun 04 Filed by: Goetz Kathleen
Jun 8, 2026 04:11 PM Form 4 Aurinia Pharmaceuticals For: Jun 04 Filed by: Nova Tina Susan
Jun 8, 2026 04:09 PM Form 4 Aurinia Pharmaceuticals For: Jun 04 Filed by: Bailey Jeffrey Allen
Jun 5, 2026 04:28 PM Form 144 Aurinia Pharmaceuticals Filed by: Keenan Greg
Jun 4, 2026 06:45 PM Form SCHEDULE 13D/A Aurinia Pharmaceuticals Filed by: TANG CAPITAL MANAGEMENT LLC
Jun 4, 2026 04:19 PM Form 8-K Aurinia Pharmaceuticals For: Jun 03
Jun 4, 2026 04:12 PM Form 144 Aurinia Pharmaceuticals Filed by: Keenan Greg
Jun 4, 2026 07:00 AM LUPKYNIS Associated with a Statistically Significant 53% Reduction in Risk of Renal-Related Event or Death
Jun 2, 2026 09:55 PM Form 4 Aurinia Pharmaceuticals For: May 29 Filed by: TANG KEVIN
View All Articles

Entities mentioned with AUPH

View All Entities